AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/114
TRANSPLANT-LITE - INDUCTION OF GRAFT-VERSUS-MALIGNANCY USING FLUDARABINE-BASED NONABLATIVE CHEMOTHERAPY AND ALLOGENEIC BLOOD PROGENITOR-CELL TRANSPLANTATION AS TREATMENT FOR LYMPHOID MALIGNANCIES
Authors: KHOURI IF KEATING M KORBLING M PRZEPIORKA D ANDERLINI P OBRIEN S GIRALT S IPPOLITI C VONWOLFF B GAJEWSKI J DONATO M CLAXTON D UENO N ANDERSSON B GEE A CHAMPLIN R
Citation: If. Khouri et al., TRANSPLANT-LITE - INDUCTION OF GRAFT-VERSUS-MALIGNANCY USING FLUDARABINE-BASED NONABLATIVE CHEMOTHERAPY AND ALLOGENEIC BLOOD PROGENITOR-CELL TRANSPLANTATION AS TREATMENT FOR LYMPHOID MALIGNANCIES, Journal of clinical oncology, 16(8), 1998, pp. 2817-2824
HIGH-DOSE CHEMOTHERAPY FOR RELAPSED AND REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA - MEDIASTINAL LOCALIZATION PREDICTS FOR A FAVORABLE OUTCOME
Authors: POPAT U PRZEPIORK D CHAMPLIN R PUGH W AMIN K MEHRA R RODRIGUEZ J GIRALT S ROMAGUERA J RODRIGUEZ A PRETI A ANDERSSON B KHOURI I CLAXTON D DELIMA M DONATO M ANDERLINI P GAJEWSKI J CABANILLAS F VANBESIEN K
Citation: U. Popat et al., HIGH-DOSE CHEMOTHERAPY FOR RELAPSED AND REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA - MEDIASTINAL LOCALIZATION PREDICTS FOR A FAVORABLE OUTCOME, Journal of clinical oncology, 16(1), 1998, pp. 63-69
ALLOGENEIC MARROW TRANSPLANTATION FOR MYELOPROLIFERATIVE DISORDERS OTHER THAN CHRONIC MYELOGENOUS LEUKEMIA - REVIEW OF 40 CASES
Authors: PRZEPIORKA D GIRALT S KHOURI I CHAMPLIN R BUESORAMOS C
Citation: D. Przepiorka et al., ALLOGENEIC MARROW TRANSPLANTATION FOR MYELOPROLIFERATIVE DISORDERS OTHER THAN CHRONIC MYELOGENOUS LEUKEMIA - REVIEW OF 40 CASES, American journal of hematology, 57(1), 1998, pp. 24-28
PHASE-II STUDY OF DACLIZUMAB FOR TREATMENT OF ACUTE GRAFT-VS-HOST DISEASE
Authors: PRZEPIORKA D KERNAN N IPPOLITI C PAPADOPOULOS E GIRALT S KHOURI I LU J GAJEWSKI J DURETT A CLEARY R CHAMPLIN R ANDERSSON B LIGHT S
Citation: D. Przepiorka et al., PHASE-II STUDY OF DACLIZUMAB FOR TREATMENT OF ACUTE GRAFT-VS-HOST DISEASE, Experimental hematology, 26(8), 1998, pp. 35-35
PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL COMPARING INTENSIVE CHEMOTHERAPY WITH GROWTH-FACTOR (GF) OR PERIPHERAL-BLOOD PROGENITOR (PBPC) CELL MOBILIZATION TO GROWTH-FACTOR ALONE FOR HEMATOPOIETIC RESCUE AFTER HIGH-DOSE CHEMOTHERAPY (HDC)
Authors: GAJEWSKI J RONDON G MIRZA N MEHRA R DONATO M ANDERLINI P KORBLING M THERIALT R KHOURI I GIRALT S BUZDAR A UENO N PRZEPIORKA D ANDERSSON B DURRETT A SALIBA R BRUTON J RAHMAN Z IPPOLITI C HORTABAQYI G RABER M BAST R CHAMPLIN R
Citation: J. Gajewski et al., PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL COMPARING INTENSIVE CHEMOTHERAPY WITH GROWTH-FACTOR (GF) OR PERIPHERAL-BLOOD PROGENITOR (PBPC) CELL MOBILIZATION TO GROWTH-FACTOR ALONE FOR HEMATOPOIETIC RESCUE AFTER HIGH-DOSE CHEMOTHERAPY (HDC), Experimental hematology, 26(8), 1998, pp. 371-371
INDUCTION OF GRAFT-VS-MALIGNANCY AS A PRIMARY THERAPEUTIC MODALITY
Authors: CHAMPLIN R KHOURI I GIRALT S
Citation: R. Champlin et al., INDUCTION OF GRAFT-VS-MALIGNANCY AS A PRIMARY THERAPEUTIC MODALITY, Experimental hematology, 26(8), 1998, pp. 486-486
IMPACT OF PROPHYLAXIS REGIMEN ON THE INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION
Authors: PRZEPIORKA D IPPOLITI C KHOURI I ANDERLINI P FOLLODER J UENO N MEHRA R GIRALT S GAJEWSKI J CLEARY K CLAXTON D CHAMPLIN R ANDERSSON B KORBLING M
Citation: D. Przepiorka et al., IMPACT OF PROPHYLAXIS REGIMEN ON THE INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 26-26
ALLOGENEIC STEM-CELL TRANSPLANTATION FOR ADVANCED HODGKINS-DISEASE - THE ANDERSON,M.D. EXPERIENCE
Authors: ANDERLINI P ANDERSSON B GAJEWSKI J GIRALT S MEHRA R CLAXTON D UENO N KHOURI I PRZEPIORKA D DONATO M KORBLING M CHAMPLIN R
Citation: P. Anderlini et al., ALLOGENEIC STEM-CELL TRANSPLANTATION FOR ADVANCED HODGKINS-DISEASE - THE ANDERSON,M.D. EXPERIENCE, Bone marrow transplantation, 21, 1998, pp. 575-575
PRELIMINARY-REPORT OF A NEW ACTIVE REGIMEN FOR AGGRESSIVE MANTLE CELLLYMPHOMA
Authors: KHOURI IF ROMAGUERA J PALMER JL PUGH WC KORBLING M SAMUELS B GIRALT S RODRIGUEZ A PRZEPIORKA D MCLAUGHLIN P ANDERSSON B CLAXTON D MIRZA N MEHRA R HAGEMEISTER F CABANILLAS F CHAMPLIN R
Citation: If. Khouri et al., PRELIMINARY-REPORT OF A NEW ACTIVE REGIMEN FOR AGGRESSIVE MANTLE CELLLYMPHOMA, British Journal of Haematology, 102(1), 1998, pp. 240-241
ANALYSIS OF CHIMERISM FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION BY FLUORESCENT-IN-SITU HYBRIDIZATION
Authors: RONDON G GIRALT S PEREIRA M VANBESIEN K MEHRA R CHAMPLIN R ANDREEFF M
Citation: G. Rondon et al., ANALYSIS OF CHIMERISM FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION BY FLUORESCENT-IN-SITU HYBRIDIZATION, Leukemia & lymphoma, 25(5-6), 1997, pp. 463-467
NATURAL-HISTORY AND STAGING OF CHRONIC MYELOGENOUS LEUKEMIA
Authors: CORTES J KANTARJIAN HM GIRALT S TALPAZ M
Citation: J. Cortes et al., NATURAL-HISTORY AND STAGING OF CHRONIC MYELOGENOUS LEUKEMIA, Bailliere's clinical haematology, 10(2), 1997, pp. 277-290
RESULTS OF DECITABINE THERAPY IN THE ACCELERATED AND BLASTIC PHASES OF CHRONIC MYELOGENOUS LEUKEMIA
Authors: KANTARJIAN HM OBRIEN SM KEATING M BERAN M ESTEY E GIRALT S KORNBLAU S RIOS MB DEVOS D TALPAZ M
Citation: Hm. Kantarjian et al., RESULTS OF DECITABINE THERAPY IN THE ACCELERATED AND BLASTIC PHASES OF CHRONIC MYELOGENOUS LEUKEMIA, Leukemia, 11(10), 1997, pp. 1617-1620
STUDIES OF DECITABINE WITH ALLOGENEIC PROGENITOR-CELL TRANSPLANTATION
Authors: GIRALT S DAVIS M OBRIEN S VANBESIEN K CHAMPLIN R DEVOS D KANTARJIAN H
Citation: S. Giralt et al., STUDIES OF DECITABINE WITH ALLOGENEIC PROGENITOR-CELL TRANSPLANTATION, Leukemia, 11, 1997, pp. 32-34
DECITABINE STUDIES IN CHRONIC AND ACUTE MYELOGENOUS LEUKEMIA
Authors: KANTARJIAN HM OBRIEN SM ESTEY E GIRALT S BERAN M RIOS MB KEATING M DEVOS D TALPAZ M
Citation: Hm. Kantarjian et al., DECITABINE STUDIES IN CHRONIC AND ACUTE MYELOGENOUS LEUKEMIA, Leukemia, 11, 1997, pp. 35-36
DONOR LEUKOCYTE INFUSIONS IN 140 PATIENTS WITH RELAPSED MALIGNANCY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: COLLINS RH SHPILBERG O DROBYSKI WR PORTER DL GIRALT S CHAMPLIN R GOODMAN SA WOLFF SN HU W VERFAILLIE C LIST A DALTON W OGNOSKIE N CHETRIT A ANTIN JH NEMUNAITIS J
Citation: Rh. Collins et al., DONOR LEUKOCYTE INFUSIONS IN 140 PATIENTS WITH RELAPSED MALIGNANCY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Journal of clinical oncology, 15(2), 1997, pp. 433-444
PHASE-I TRIAL OF CYCLOSPORINE-INDUCED AUTOLOGOUS GRAFT-VERSUS-HOST DISEASE IN PATIENTS WITH MULTIPLE-MYELOMA UNDERGOING HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL RESCUE
Authors: GIRALT S WEBER D COLOME M DIMOPOULOS M MEHRA R VANBESIEN K GAJEWSKI J ANDERSSON B KHOURI I PRZEPIORKA D VONWOLFF B DELASALLE K KORBLING M SEONG D ALEXANIAN R CHAMPLIN R
Citation: S. Giralt et al., PHASE-I TRIAL OF CYCLOSPORINE-INDUCED AUTOLOGOUS GRAFT-VERSUS-HOST DISEASE IN PATIENTS WITH MULTIPLE-MYELOMA UNDERGOING HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL RESCUE, Journal of clinical oncology, 15(2), 1997, pp. 667-673
USE OF OCTREOTIDE IN THE SYMPTOMATIC MANAGEMENT OF DIARRHEA INDUCED BY GRAFT-VERSUS-HOST DISEASE IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
Authors: IPPOLITI C CHAMPLIN R BUGAZIA N PRZEPIORKA D NEUMANN J GIRALT S KHOURI I GAJEWSKI J
Citation: C. Ippoliti et al., USE OF OCTREOTIDE IN THE SYMPTOMATIC MANAGEMENT OF DIARRHEA INDUCED BY GRAFT-VERSUS-HOST DISEASE IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES, Journal of clinical oncology, 15(11), 1997, pp. 3350-3354
INDUCTION OF GRAFT-VERSUS-LEUKEMIA USING FLUDARABINE-BASED ALLOGENEICMINI-TRANSPLANTS AS TREATMENT FOR LYMPHOID MALIGNANCIES
Authors: KHOURI I KEATING M KORBLING M PRZEPIORKA D ANDERLINI P OBRIEN S VONWOLFF B GIRALT S GAJEWSKI J MEHRA R KANTARJIAN H CHAMPLIN R
Citation: I. Khouri et al., INDUCTION OF GRAFT-VERSUS-LEUKEMIA USING FLUDARABINE-BASED ALLOGENEICMINI-TRANSPLANTS AS TREATMENT FOR LYMPHOID MALIGNANCIES, Experimental hematology, 25(8), 1997, pp. 25-25
FOSCARNET FOR PREVENTION OF CYTOMEGALOVIRUS-INFECTION IN ALLOGENEIC MARROW TRANSPLANT RECIPIENTS UNABLE TO RECEIVE GANCICLOVIR
Authors: IPPOLITI C MORGAN A WARKENTIN D VANBESIEN K MEHRA R KHOURI I GIRALT S GAJEWSKI J CHAMPLIN R ANDERSSON B PRZEPIORKA D
Citation: C. Ippoliti et al., FOSCARNET FOR PREVENTION OF CYTOMEGALOVIRUS-INFECTION IN ALLOGENEIC MARROW TRANSPLANT RECIPIENTS UNABLE TO RECEIVE GANCICLOVIR, Bone marrow transplantation, 20(6), 1997, pp. 491-495
USEFULNESS OF DETECTION OF MINIMAL RESIDUAL DISEASE BY HYPERMETAPHASEFLUORESCENT IN-SITU HYBRIDIZATION AFTER ALLOGENEIC BMT FOR CHRONIC MYELOGENOUS LEUKEMIA
Authors: SEONG D GIRALT S FISCHER H HAYES K GLASSMAN A ARLINGHAUS R XU J KANTARJIAN H SICILIANO M CHAMPLIN R
Citation: D. Seong et al., USEFULNESS OF DETECTION OF MINIMAL RESIDUAL DISEASE BY HYPERMETAPHASEFLUORESCENT IN-SITU HYBRIDIZATION AFTER ALLOGENEIC BMT FOR CHRONIC MYELOGENOUS LEUKEMIA, Bone marrow transplantation, 19(6), 1997, pp. 565-570
ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION IN ADVANCED HEMATOLOGIC CANCERS
Authors: PRZEPIORKA D ANDERLINI P IPPOLITI C KHOURI I FIETZ T THALL P MEHRA R GIRALT S GAJEWSKI J DEISSEROTH AB CLEARY K CHAMPLIN R VANBESIEN K ANDERSSON B KORBLING M
Citation: D. Przepiorka et al., ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION IN ADVANCED HEMATOLOGIC CANCERS, Bone marrow transplantation, 19(5), 1997, pp. 455-460
REDEPOSITIONAL OR CLIMATE EVENT IN IBERIA DURING THE BOREAL
Authors: JULIA R BURJACHS F GIRALT S
Citation: R. Julia et al., REDEPOSITIONAL OR CLIMATE EVENT IN IBERIA DURING THE BOREAL, JQS. Journal of quaternary science, 12(1), 1997, pp. 73-74
COMPLETE REMISSION OF REFRACTORY GESTATIONAL TROPHOBLASTIC DISEASE WITH BRAIN METASTASES TREATED WITH MULTICYCLE IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE (ICE) AND STEM-CELL RESCUE
Authors: VANBESIEN K VERSCHRAEGEN C MEHRA R GIRALT S KUDELKA AP EDWARDS CL PIAMSONBOOM S TERMRUNGRUANGLERT W CHAMPLIN R KAVANAGH JJ
Citation: K. Vanbesien et al., COMPLETE REMISSION OF REFRACTORY GESTATIONAL TROPHOBLASTIC DISEASE WITH BRAIN METASTASES TREATED WITH MULTICYCLE IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE (ICE) AND STEM-CELL RESCUE, Gynecologic oncology, 65(2), 1997, pp. 366-369
SURVIVAL OF PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA RELAPSING AFTER BONE-MARROW TRANSPLANTATION - COMPARISON WITH PATIENTS RECEIVING CONVENTIONAL CHEMOTHERAPY
Authors: ZHANG MJ BACCARANI M GALE RP MCGLAVE PB ATKINSON K CHAMPLIN RE DICKE KA GIRALT S GLUCKMAN E GOLDMAN JM KLEIN JP HERZIG RH MASAOKA T OREILLY RJ ROZMAN C ROWLINGS PA SOBOCINSKI KA SPECK B ZWAAN FE HOROWITZ MM
Citation: Mj. Zhang et al., SURVIVAL OF PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA RELAPSING AFTER BONE-MARROW TRANSPLANTATION - COMPARISON WITH PATIENTS RECEIVING CONVENTIONAL CHEMOTHERAPY, British Journal of Haematology, 99(1), 1997, pp. 23-29
ALLOGENEIC BLOOD OR MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - TIMING OF TRANSPLANTATION AND POTENTIAL EFFECT OF FLUDARABINEON ACUTE GRAFT-VERSUS-HOST DISEASE
Authors: KHOURI IF PRZEPIORKA D VANBESIEN K OBRIEN S PALMER JL LERNER S MEHRA RC VRIESENDORP HM ANDERSSON BS GIRALT S KORBLING M KEATING MJ CHAMPLIN RE
Citation: If. Khouri et al., ALLOGENEIC BLOOD OR MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - TIMING OF TRANSPLANTATION AND POTENTIAL EFFECT OF FLUDARABINEON ACUTE GRAFT-VERSUS-HOST DISEASE, British Journal of Haematology, 97(2), 1997, pp. 466-473
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>